Finally, SGLT-2i also could result in erythropoiesis and improve oxygen delivery to tissues (34) and modulate inflammatory and oxidative mediators such as leptin, interleukins (IL), tumor necrosis factor α, cyclooxygenase 2 (COX-2) to decrease the frequency of HF-related hospitalizations (35). The gene discussed is TNF; the disease is hydrops fetalis.